Ask AI
ProCE Banner Activity

Expert Answers to Frequently Asked Questions About Chronic Myeloid Leukemia

Clinical Thought

This expert commentary offers practical insights into the current care of patients with chronic-phase chronic myeloid leukemia (CP-CML), including treatment choice, management of long-term toxicities, and the pursuit of treatment-free remission.

Released: October 22, 2025

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Disclosure

Primary Author

Michael J. Mauro, MD: researcher: Enliven, Novartis, Takeda, Terns; consultant/advisor/speaker: Bristol Myers Squibb, Enliven, Novartis, Pfizer, Terns.